Clinical Trial News and Research

RSS
NCI survey: Most people do not know much about clinical trials

NCI survey: Most people do not know much about clinical trials

FightSMA to host panel discussions on spinal muscular atrophy

FightSMA to host panel discussions on spinal muscular atrophy

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

C3 Jian, West China School of Stomatology to create joint CRC to test oral healthcare products

C3 Jian, West China School of Stomatology to create joint CRC to test oral healthcare products

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX first quarter revenue is $3.2 million for 2011

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

FDA approves Abbott's AndroGel for hypogonadism treatment in men

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers report Avastin is effective as Lucentis for AMD treatment

New PET imaging clinical trial to improve early esophageal, lung cancer detection

New PET imaging clinical trial to improve early esophageal, lung cancer detection

Ramipril can effectively reduce risk of ESRD in obese patients

Ramipril can effectively reduce risk of ESRD in obese patients

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

Curis reports first quarter net loss of $6.8 million

Curis reports first quarter net loss of $6.8 million

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

AVEO reports total revenue of $133.6 million for first quarter 2011

AVEO reports total revenue of $133.6 million for first quarter 2011

Guided Therapeutics' cervical detection technology design, branding to be presented at ACOG

Guided Therapeutics' cervical detection technology design, branding to be presented at ACOG

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Positive results from Shire's Vyvanse clinical trial in schizophrenia

GSN receives NIH grant for non-invasive prenatal test trial in genetic abnormalities

GSN receives NIH grant for non-invasive prenatal test trial in genetic abnormalities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.